BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28437363)

  • 1. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
    Beyea JA; Instrum RS; Agrawal SK; Parnes LS
    Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic Triamcinolone and Dexamethasone in the Treatment of Ménière's Syndrome.
    Jumaily M; Faraji F; Mikulec AA
    Otol Neurotol; 2017 Mar; 38(3):386-391. PubMed ID: 28192380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated courses of intratympanic dexamethasone injection are effective for intractable Meniere's disease.
    Leng Y; Liu B; Zhou R; Liu J; Liu D; Zhang SL; Kong WJ
    Acta Otolaryngol; 2017 Feb; 137(2):154-160. PubMed ID: 27650470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.
    Boleas-Aguirre MS; Lin FR; Della Santina CC; Minor LB; Carey JP
    Otol Neurotol; 2008 Jan; 29(1):33-8. PubMed ID: 18199956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF; Poe DS
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
    Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
    Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
    Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
    Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K; Ata N
    Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere's Disease.
    Yazdani N; Nejadian F; Rezazadeh N; Hoseinabadi R; Karimi E; Gharibi R; Dabiri S
    Acta Med Iran; 2018 Jan; 56(1):43-48. PubMed ID: 29436794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
    Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic steroid injections for intractable Ménière's disease.
    Barrs DM; Keyser JS; Stallworth C; McElveen JT
    Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease].
    Wang QL; Guo XD; Mei XS; Li Y; Yao WJ; Yang XG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):96-99. PubMed ID: 29871195
    [No Abstract]   [Full Text] [Related]  

  • 20. Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.
    Lambert PR; Carey J; Mikulec AA; LeBel C;
    Otol Neurotol; 2016 Dec; 37(10):1669-1676. PubMed ID: 27749754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.